Research ArticleLiver disease

Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis

See allHide authors and affiliations

Science Translational Medicine  27 Nov 2019:
Vol. 11, Issue 520, eaav9701
DOI: 10.1126/scitranslmed.aav9701

Article Information

vol. 11 no. 520

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 6, 2018
  • Resubmitted February 25, 2019
  • Accepted for publication November 8, 2019
  • .

Author Information

  1. Neeta B. Amin1,*,
  2. Santos Carvajal-Gonzalez2,
  3. Julie Purkal1,
  4. Tong Zhu2,
  5. Collin Crowley1,
  6. Sylvie Perez1,
  7. Kristin Chidsey2,
  8. Albert M. Kim1 and
  9. Bryan Goodwin1
  1. 1Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, MA 02139, USA.
  2. 2Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, MA 02139, USA.
  1. *Corresponding author. Email: neeta.amin{at}pfizer.com

Altmetric

Article usage

Article usage: November 2019 to December 2019

AbstractFullPdf
Nov 20192509344216
Dec 20192203482358